Salesforce Valuation
Is CRM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CRM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRM * (MX$4712) is trading below our estimate of fair value (MX$5225.02)
Significantly Below Fair Value: CRM * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRM *?
Other financial metrics that can be useful for relative valuation.
What is CRM *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$266.06b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.6x |
Enterprise Value/EBITDA | 28.8x |
PEG Ratio | 3.4x |
Price to Earnings Ratio vs Peers
How does CRM *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 61.2x | ||
ADBE Adobe | 44.1x | 17.1% | US$213.9b |
SAP SAP | 77.3x | 33.2% | €198.9b |
INTU Intuit | 64.5x | 17.4% | US$178.2b |
SNPS Synopsys | 59x | 13.8% | US$82.9b |
CRM * Salesforce | 64.7x | 18.8% | Mex$266.1b |
Price-To-Earnings vs Peers: CRM * is expensive based on its Price-To-Earnings Ratio (64.7x) compared to the peer average (61.2x).
Price to Earnings Ratio vs Industry
How does CRM *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Earnings vs Industry: CRM * is expensive based on its Price-To-Earnings Ratio (64.7x) compared to the Global Software industry average (33.4x).
Price to Earnings Ratio vs Fair Ratio
What is CRM *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 64.7x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CRM *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$4,712.00 | Mex$5,782.13 +22.7% | 8.2% | Mex$6,687.17 | Mex$3,960.86 | n/a | 41 |
Apr ’25 | Mex$5,024.00 | Mex$5,524.85 +10.0% | 8.0% | Mex$6,460.00 | Mex$3,826.31 | n/a | 44 |
Mar ’25 | Mex$5,398.00 | Mex$5,553.61 +2.9% | 10.1% | Mex$6,637.25 | Mex$3,931.30 | n/a | 46 |
Feb ’25 | Mex$4,870.50 | Mex$4,917.68 +1.0% | 11.9% | Mex$6,691.89 | Mex$3,637.64 | n/a | 45 |
Jan ’25 | Mex$4,464.00 | Mex$4,684.29 +4.9% | 11.5% | Mex$5,943.04 | Mex$2,699.84 | n/a | 46 |
Dec ’24 | Mex$4,475.00 | Mex$4,646.74 +3.8% | 10.9% | Mex$5,932.97 | Mex$2,734.32 | n/a | 46 |
Nov ’24 | Mex$3,538.01 | Mex$4,663.24 +31.8% | 11.6% | Mex$6,229.07 | Mex$2,913.01 | n/a | 46 |
Oct ’24 | Mex$3,549.00 | Mex$4,386.89 +23.6% | 11.6% | Mex$5,820.29 | Mex$2,721.84 | n/a | 47 |
Sep ’24 | Mex$3,750.00 | Mex$4,352.15 +16.1% | 12.0% | Mex$5,811.04 | Mex$2,717.52 | n/a | 46 |
Aug ’24 | Mex$3,784.00 | Mex$4,074.90 +7.7% | 12.2% | Mex$5,508.91 | Mex$2,561.89 | n/a | 46 |
Jul ’24 | Mex$3,624.71 | Mex$4,102.15 +13.2% | 11.2% | Mex$5,566.34 | Mex$2,620.46 | n/a | 45 |
Jun ’24 | Mex$3,741.85 | Mex$4,154.30 +11.0% | 12.3% | Mex$5,704.86 | Mex$2,685.67 | n/a | 45 |
May ’24 | Mex$3,565.00 | Mex$4,114.00 +15.4% | 16.4% | Mex$6,909.68 | Mex$2,607.09 | n/a | 46 |
Apr ’24 | Mex$3,608.98 | Mex$4,183.42 +15.9% | 16.6% | Mex$7,049.75 | Mex$2,659.94 | Mex$5,024.00 | 47 |
Mar ’24 | Mex$3,033.65 | Mex$3,654.11 +20.5% | 23.1% | Mex$7,061.94 | Mex$2,186.76 | Mex$5,398.00 | 47 |
Feb ’24 | Mex$3,198.80 | Mex$3,666.78 +14.6% | 24.0% | Mex$7,213.00 | Mex$2,233.53 | Mex$4,870.50 | 47 |
Jan ’24 | Mex$2,570.00 | Mex$3,896.67 +51.6% | 17.9% | Mex$6,139.64 | Mex$2,653.91 | Mex$4,464.00 | 45 |
Dec ’23 | Mex$2,811.95 | Mex$3,890.69 +38.4% | 16.9% | Mex$5,938.27 | Mex$2,873.36 | Mex$4,475.00 | 46 |
Nov ’23 | Mex$3,157.00 | Mex$4,380.60 +38.8% | 16.0% | Mex$6,316.82 | Mex$3,008.01 | Mex$3,538.01 | 47 |
Oct ’23 | Mex$2,919.00 | Mex$4,430.31 +51.8% | 17.7% | Mex$7,679.44 | Mex$2,991.99 | Mex$3,549.00 | 46 |
Sep ’23 | Mex$3,087.65 | Mex$4,577.15 +48.2% | 16.9% | Mex$7,755.67 | Mex$3,021.69 | Mex$3,750.00 | 47 |
Aug ’23 | Mex$3,739.96 | Mex$5,058.90 +35.3% | 17.0% | Mex$7,878.33 | Mex$3,581.06 | Mex$3,784.00 | 46 |
Jul ’23 | Mex$3,393.03 | Mex$5,070.84 +49.4% | 17.5% | Mex$7,750.40 | Mex$3,522.91 | Mex$3,624.71 | 46 |
Jun ’23 | Mex$3,528.55 | Mex$5,021.64 +42.3% | 17.7% | Mex$7,585.85 | Mex$3,448.11 | Mex$3,741.85 | 48 |
May ’23 | Mex$3,616.89 | Mex$5,977.19 +65.3% | 13.5% | Mex$7,775.92 | Mex$4,503.98 | Mex$3,565.00 | 46 |
Apr ’23 | Mex$4,214.95 | Mex$5,950.00 +41.2% | 13.4% | Mex$7,679.63 | Mex$4,488.10 | Mex$3,608.98 | 46 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.